Best Telehealth Clinics in Maryland (2026)

Maryland's telehealth statute is codified at Health Occ. § 1-1001 through § 1-1005. The law defines telehealth broadly and does not impose a blanket in-person visit requirement before prescribing controlled substances via telemedicine. Maryland relies on the federal DEA framework for controlled substance telehealth prescribing, supplemented by the DEA flexibility extension through December 31, 2026.

There is one major exception. Health Occ. § 1-1003(c) prohibits prescribing opioids for pain management through telehealth unless the patient is located in a facility with a DEA-registered provider present. This effectively bans telehealth-only opioid prescribing for pain outside of clinical settings. Testosterone (Schedule III) is not an opioid and is not affected by this restriction. GLP-1s, hair loss drugs, ED medications, and HRT are also unaffected.

Maryland was an early IMLC adopter. The state joined the Interstate Medical Licensure Compact, and out-of-state physicians can obtain expedited Maryland licensure through the compact process. This supports broader provider availability compared to non-compact states like California, New York, and Massachusetts.

HB 123 (2021) made COVID-era audio-only telehealth coverage permanent for Medicaid. Commercial payer audio-only requirements were extended through June 30, 2025. The status of commercial audio-only coverage after that date is uncertain. Video telehealth coverage parity is permanent under Maryland law.

Maryland has a Board of Physicians (MBP) that oversees telehealth practice standards. The MBP has not issued specific guidance restricting telehealth prescribing of testosterone or other non-opioid controlled substances. The board's position is that telehealth prescribing must meet the same standard of care as in-person prescribing, which is the default standard used in most states.

Maryland requires electronic prescribing for Schedule II through V controlled substances under Health Gen. § 21-2A-04, consistent with federal EPCS requirements. Pharmacies must verify the prescriber holds a valid Maryland license or is practicing under an applicable interstate compact or telehealth registration.

Maryland has 6.2 million residents and sits in the Baltimore-Washington corridor, giving it access to providers licensed in both Maryland and the District of Columbia. Provider availability is good, supported by IMLC membership and the absence of an in-person requirement for non-opioid controlled substances.

All major TRT providers serve Maryland. Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, 45 states including MD), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available. Defy Medical ($200/mo) also serves the state.

GLP-1 availability is unrestricted. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, MEDVi, Shed, Sunlight, and Mochi Health all serve Maryland. Pricing ranges from $99/mo to $399/mo.

All HRT, hair loss, and ED providers with national coverage serve Maryland. Midi Health accepts insurance. PlushCare accepts major Maryland insurers including CareFirst BlueCross BlueShield.

Enhance MD's 11-state exclusion list does not appear to include Maryland. No known state-specific provider exclusions for MD outside of providers that only operate in a handful of states.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year), Defy Medical $200/mo ($2,800/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Maryland Medicaid does not cover GLP-1 receptor agonists for weight loss as of April 2026. Coverage is limited to diabetes indications. Patients seeking GLP-1s for weight management in Maryland must pay out of pocket or use commercial insurance with obesity drug coverage.

Maryland does not tax prescription medications. The state sales tax is 6% but Rx drugs are exempt. Maryland has a progressive income tax ranging from 2% to 5.75%, plus county income taxes that add 2.25% to 3.2% depending on the county. This does not affect telehealth pricing directly but impacts overall cost of living.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo), Alloy ($49/mo). ED: Hims $17/mo to MEDVi $119/mo.

Maryland's proximity to DC means some patients may have access to providers licensed in both jurisdictions, potentially expanding options. However, telehealth prescriptions must be written by a provider licensed in the state where the patient is physically located at the time of the consultation.

TRT (testosterone replacement therapy)

No in-person requirement for TRT prescribing via telehealth in Maryland. The opioid restriction under Health Occ. § 1-1003(c) does not apply to testosterone. The federal DEA waiver through December 2026 provides the basis for telehealth Schedule III prescribing. Both compounded and FDA-approved testosterone are available. Electronic prescribing required for Schedule II through V.

GLP-1 weight loss

No state-specific GLP-1 restrictions in Maryland. Federal FDA compounding rules apply. Maryland Medicaid does not cover GLP-1s for obesity — only for diabetes. Commercial insurance coverage varies by plan. Compounded semaglutide is available from telehealth providers subject to federal compounding regulations.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Maryland. No additional state restrictions apply. All national HRT providers serve the state.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Maryland. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Maryland. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Maryland. Non-controlled peptides like BPC-157 and sermorelin have fewer prescribing barriers. The opioid restriction does not affect peptide prescriptions. IMLC membership supports peptide provider availability.